Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Tolerability, and Pharmacokinetics of Staccato Fentanyl for Inhalation in Normal, Healthy Volunteers.

Trial Profile

Safety, Tolerability, and Pharmacokinetics of Staccato Fentanyl for Inhalation in Normal, Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Fentanyl (Primary) ; Fentanyl
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 24 Mar 2009 ClinicalTrials.gov has reported additional lead trial investigators, actual number of patients as 51, Alexza Pharmaceuticals as trial sponsor. Official title amended.
    • 24 Mar 2009 Actual end date (1 Nov 2006) added as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top